Dr. Reema Kapoor X Ray And Imaging Centre Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-12-2024
- Paid Up Capital ₹ 0.10 M
as on 17-12-2024
- Company Age 15 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.83 M
as on 17-12-2024
- Revenue -6.19%
(FY 2020)
- Profit -84.14%
(FY 2020)
- Ebitda -68.10%
(FY 2020)
- Net Worth -18.23%
(FY 2020)
- Total Assets -25.99%
(FY 2020)
About Dr. Reema Kapoor X Ray And Imaging Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.83 M.
Ashok Kapoor, Reema Kapoor, and Harshit Kapoor serve as directors at the Company.
- CIN/LLPIN
U85190HR2009PTC039354
- Company No.
039354
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Aug 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Faridabad, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dr. Reema Kapoor X Ray And Imaging Centre?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Kapoor  | Managing Director | 05-Aug-2009 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Reema Kapoor | Director | 05-Aug-2009 | Current |
| Harshit Kapoor | Director | 25-Apr-2024 | Current |
Financial Performance of Dr. Reema Kapoor X Ray And Imaging Centre.
Dr. Reema Kapoor X Ray And Imaging Centre Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 6.19% decrease. The company also saw a substantial fall in profitability, with a 84.14% decrease in profit. The company's net worth observed a substantial decline by a decrease of 18.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr. Reema Kapoor X Ray And Imaging Centre?
In 2020, Dr. Reema Kapoor X Ray And Imaging Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
India Infoline Finance Limited Creation Date: 30 Nov 2012 | ₹3.83 M | Open |
How Many Employees Work at Dr. Reema Kapoor X Ray And Imaging Centre?
Unlock and access historical data on people associated with Dr. Reema Kapoor X Ray And Imaging Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. Reema Kapoor X Ray And Imaging Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Reema Kapoor X Ray And Imaging Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
